Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Igene Biotechnology Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Igene Biotechnology Inc since year 2005.
Table 2 shows the detailed insider transactions of Igene Biotechnology Inc since 2005.
The reporting company's ticker symbol is IGNE. The reporting company's CIK number is 793160.
The total value of stock buying since 2005 is $20,900.
The total value of stock sales since 2005 is $52,000.
The total value of stock option exercises since 2005 is $1,697,555.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2010-10-20||Kimelman Michael (Chairman of the Board)||Sale||8,000,000||.00||24,000|
|2009-07-16||Weiseberger Edward J (Chief Financial Officer)||Option Ex||3,979,697||.01||23,878|
|2009-07-16||Hiu Stephen F (President)||Option Ex||9,650,000||.01||57,900|
|2009-07-16||Monahan Patrick F (Director)||Option Ex||4,861,667||.01||29,170|
|2009-07-16||Kimelman Michael (Chairman of the Board)||Option Ex||20,086,970||.01||120,521|
|2008-12-09||Hiu Stephen F (President)||Option Ex||728,000||.01||8,736|
|2008-12-09||Monahan Patrick F (Director)||Option Ex||728,000||.01||8,736|
|2008-12-09||Kimelman Michael (CHAIRMAN OF THE BOARD)||Option Ex||120,717,844||.01||1,448,614|
|2006-12-19||Kempner Thomas L (Director)||Buy||100,000||.02||2,500|
|2006-08-17||Kempner Thomas L (Director)||Buy||460,000||.04||18,400|
|2006-08-17||Kempner Thomas L (Director)||Sale||300,000||.04||12,000|
|2006-06-28||Kempner Thomas L (Director)||Sale||400,000||.04||16,000|
Insider trading activities including stock purchases, stock sales, and option exercises of IGNE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Igene Biotechnology Inc (symbol IGNE, CIK number 793160) see the Securities and Exchange Commission (SEC) website.